Navigation Links
Corporate Financial Planning Experts Gather at IE – Innovation Enterprise’s Financial Planning & Analysis for Pharma & Biotech Summit
Date:2/21/2013

Philadelphia, Pennsylvania (PRWEB) February 21, 2013

Within an ever-changing business environment there is an unquestionable need for organizations to become analytically competitive, innovative and agile. Building on IE. – Innovation Enterprise’s history of successful summits in this sector, the Financial Planning & Analysis for Pharma & Biotech event will bring together over 200+ senior finance leaders in a unique, collaborative environment.

With over 25 distinguished keynote speakers including: Director, Finance, Pfizer, Senior Director, Finance, Johnson & Johnson and Senior Director, Finance, Siemens Healthcare, this summit will provide attendees with an exclusive insight into processes at the most forward thinking organizations currently in the industry.

Commenting on the 2012 event a previous attendee noted: “This summit is unique in that it covers both financially and industry relevant topics. It’s an excellent opportunity to share and exchange information and knowledge with high level and international professionals.” From the 120 delegates at last year’s event, over 80% recommended the event to a colleague with a further 87% rating the summit as “good to excellent”.

Emma Flanagan, International Events Director at IE. – Innovation Enterprise: “From our research into the market it became clear that finance leaders are looking for a forum to exchange ideas with peers of a similar stature and experience. This summit was specifically designed for senior level attendees. It’s exclusive, CPE accredited and we’re really proud of the agenda that we’ve organized.”

Running concurrently to the Pharma & Biotech summit is the Financial Planning & Analysis in Healthcare Summit where speakers from companies such as the American Academy of Physician Assistants and DaVita will be congregating to discuss their challenges and best practices in a no holds barred environment.

For a complete list of speakers, agenda and registration details for the Financial Planning & Analysis for Pharma & Biotech Summit please visit: http://finance.theiegroup.com/fpa-pharma

About IE.: The Innovation Enterprise Ltd, a CFO Publishing company is an independent business-to-business multi-channel media brand focused on the information needs of Senior Finance, Operations, Planning, Strategy, Decision Support & Advanced Analytics executives. Products include IE.Summits, IE.Finance, IE.Analytics, IE.Operations, IE.Strategy, IE.Membership and IE.Insights. Whether it's delivered online, or in person, everything IE produces reflects the company's unshakeable belief in the power of information to spur innovation.

Read the full story at http://www.prweb.com/releases/2013/2/prweb10450140.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. China Cord Blood Corporation Announces Completion of Corporate Structure Consolidation
2. Novus Biologicals Hires David Eansor to Lead New Corporate-Development Effort
3. Amarantus Bioscience Launches Online Corporate Communication Channels
4. China Cord Blood Corporation to Further Consolidate its Corporate Structure
5. 2012 Battalia Winston Survey Finds Corporate Holiday Parties are Making a Comeback
6. Genomatica, Inc., Award-Winning Industrial Biotechnology Pioneer, Selects Alexandria Real Estate Equities, Inc. for Long-Term, Mission-Critical R&D Facility and Corporate Headquarters
7. CTI Appoints Monique Greer, Senior Vice President, Corporate Communications and Investor Relations
8. New "GMO Inside" Campaign Denounces Corporate Disinformation Campaign That Defeated Californias Prop 37
9. Amgen Names Ray Jordan Senior Vice President, Corporate Affairs
10. BioLife Solutions Completes Corporate Facilities Expansion, Build-Out of Additional cGMP Clean Room Manufacturing Suite
11. Amarantus BioSciences Corporate Overview to be Webcast Live Today from OneMedForum 2012 Conference in NYC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)... June 23, 2016  The Prostate Cancer Foundation (PCF) is pleased ... and faster cures for prostate cancer. Members of the Class of 2016 were ... Read More About the Class of 2016 PCF Young ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample tracking software ... State Crime Laboratory, has joined STACS DNA as a Field Application Specialist. , ... Tremblay, President and COO of STACS DNA. “In further expanding our capacity as a ...
(Date:6/23/2016)... , June 23, 2016 ... Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... , the peer-reviewed journal from touchONCOLOGY, Andrew ... escalating cost of cancer care is placing an ... result of expensive biologic therapies. With the patents ...
Breaking Biology Technology:
(Date:6/3/2016)... Das DOTM (Department ... hat ein 44 Millionen $-Projekt ... einschließlich Personalisierung, Registrierung und IT-Infrastruktur, an Decatur ... Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte internationale Anbieter ... aber Decatur wurde als konformste und innovativste ...
(Date:5/24/2016)... patient care by providing unparalleled technology to leaders of the medical imaging industry.  As ... added to the range of products distributed by Ampronix. Photo - ... ... ... ...
(Date:5/3/2016)...  Neurotechnology, a provider of high-precision biometric identification ... Identification System (ABIS) , a complete system for ... can process multiple complex biometric transactions with high ... face or iris biometrics. It leverages the core ... MegaMatcher Accelerator , which have been used in ...
Breaking Biology News(10 mins):